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Catalase Prevents Maternal Diabetes–Induced Perinatal
Programming via the Nrf2–HO-1 Defense System
Shiao-Ying Chang,1 Yun-Wen Chen,1 Xin-Ping Zhao,1 Isabelle Chenier,1 Stella Tran,1
Alexandre Sauvé,1 Julie R. Ingelﬁnger,2 and Shao-Ling Zhang1
We investigated whether overexpression of catalase (CAT) in renal
proximal tubular cells (RPTCs) could prevent the programming of
hypertension and kidney disease in the offspring of dams with
maternal diabetes. Male offspring of nondiabetic and diabetic
dams from two transgenic (Tg) lines (Hoxb7-green ﬂuorescent
protein [GFP]-Tg [controls] and Hoxb7/CAT-GFP-Tg, which over-
express CAT in RPTCs) were studied from the prenatal period
into adulthood. Nephrogenesis, systolic blood pressure, renal hyper-
ﬁltration, kidney injury, and reactive oxygen species (ROS) gener-
ation were assessed. Gene expression of transforming growth
factor-b1 (TGF-b1), nuclear factor erythroid 2p45–related factor-2
(Nrf2), and heme oxygenase-1 (HO-1) was tested in both in vitro
and in vivo studies. Renal dysmorphogenesis was observed in off-
spring of Hoxb7-GFP-Tg dams with severe maternal diabetes; the
affected male offspring displayed higher renal ROS generation and
developed hypertension and renal hyperﬁltration as well as renal
injury with heightened TGF-b1 expression in adulthood. These
changes were ameliorated in male offspring of diabetic Hoxb7/
CAT-GFP-Tg dams via the Nrf2–HO-1 defense system. CAT pro-
moted Nrf2 nuclear translocation and HO-1 gene expression, seen
in both in vitro and in vivo studies. In conclusion, CAT overex-
pression in the RPTCs ameliorated maternal diabetes–induced
perinatal programming, mediated, at least in part, by triggering
the Nrf2–HO-1 defense system. Diabetes 61:2565–2574, 2012
Gestational diabetes occurs in 3–14% of pregnan-cies worldwide (www.diabetes.com), confer-ring substantial risk to the offspring. Infants ofdiabetic mothers are thus prone to developing
a variety of diseases later in life, such as metabolic syn-
drome, hypertension, and chronic kidney disease (1,2). This
phenomenon, in which intrauterine events are linked with
later changes, is termed “perinatal programming,” but the
mechanisms by which it occurs are incompletely delineated
(3,4).
The broad spectrum of birth defects seen in the offspring
of women with gestational diabetes and in animal models is
thought to be associated with either increased reactive
oxygen species (ROS) or diminished antioxidant defense
systems (both enzymatic and nonenzymatic defense systems),
leading to increased susceptibility to ROS-induced injury
in multiple tissues, including the kidney (5–7). Studies to
determine whether antioxidant supplementation or the pro-
vision of nonenzymatic antioxidants prevents these abnor-
malities are needed. To date, reports on the efﬁcacy of
antioxidant supplementation to pregnant women with or
without diabetes are preliminary and controversial (8,9), as
is the case in experimental models (7). Hence, the current
study focuses on antioxidant enzymatic pathways, speciﬁ-
cally the catalase (CAT)-nuclear factor erythroid 2p45-
related factor-2 (Nrf2)–heme oxygenase-1 (HO-1) pathway.
The key initial step in the formation of all ROS is the
conversion of oxygen to superoxide anion (O2
$2). O2
$2 has
a very short half-life and is rapidly converted to less-reactive
hydrogen peroxide (H2O2) by superoxide dismutases and
then reduced to H2O by CAT and glutathione peroxidase
(10,11). In the kidneys, CAT is localized to the renal prox-
imal tubular cells (RPTCs) (12–14). CAT has been postu-
lated to be a key enzyme regulating H2O2 levels because
cells overexpressing CAT are more resistant to H2O2 tox-
icity and oxidant-mediated injury (15,16), whereas over-
expression of glutathione peroxidase alone is not protective
against renal injury in diabetic mice (17).
Nrf2 is a transcriptional factor that acts as a key regulator
of cellular antioxidant enzymes, including CAT, HO-1, su-
peroxide dismutases, glutathione S-transferase, peroxidase,
NAD(P)H quinone oxidoreductase, and thioredoxin, among
others (18), by binding to the antioxidant response element
to defend against oxidative stress (18,19). Under basal
conditions, Nrf2 is bound within the cytoplasm to protein
Kelch-like erythroid cell-derived protein with Cap‘n’collar
homology-associated protein 1 (Keap1, an oxidative stress
sensor) and then undergoes rapid ubiquitination, with sub-
sequent proteasome-dependent degradation. Upon expo-
sure of cells to oxidative stress, Nrf2 is released from Keap1
and translocates to the nucleus, where it subsequently
guides expression of antioxidant stress genes to trigger
the cellular antioxidant defense response (18,19).
Nrf2 is highly expressed in the kidney (19), and it is
thought that the Nrf2–HO-1 defense system is renoprotective
and that its induction might even improve kidney function in
renal ﬁbrosis (20), diabetic nephropathy (21), and ischemic
acute kidney injury (22), as well as in the progression of
focal glomerulosclerosis (23,24). Moreover, HO-1 induction
has been considered as a useful target for the development
of antihypertensive drugs, since HO-1 or its metabolites can
attenuate the development of hypertension and lower blood
pressure (BP) in models of established hypertension (25).
Previously, we reported that a high-glucose milieu ex vivo
or severe maternal diabetes in utero (deﬁned as maternal
blood glucose concentration ;30 mmol/L) induces ROS
generation, which impairs nephrogenesis, resulting in off-
spring with relatively smaller kidneys and nascent nephron
deﬁciency due to excessive apoptosis (through activation of
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the nuclear factor-kB [NF-kB] and p53 pathways) (26–28).
Moreover, we have shown that severe maternal diabetes is
linked to low birth weight in offspring (mean decrease =
20%), which then manifests hypertension, glucose intol-
erance, and kidney injury in adulthood, as well as with
heightened ROS generation (26,29). Taken together, our
prior data suggest that an imbalance between ROS pro-
duction and antioxidative capacity can lead to a state of
“oxidative stress” that is intimately associated with perina-
tal programming of hypertension and kidney disease.
In the present studies, we investigated whether over-
expression of CAT in RPTCs could prevent the perinatal
programming of hypertension and kidney injury in male
offspring of diabetic dams and examined the potential un-
derlying mechanisms both in vivo and in vitro.
RESEARCH DESIGN AND METHODS
Animal models. We used both Hoxb7-green ﬂuorescent protein (GFP)–
transgenic (Tg) (Hoxb7-GFP-Tg) and Hoxb7/CAT-GFP-Tg (Hoxb7/CAT-GFP-Tg)
murine lines (both in C57/BL6 background); both lines are fertile, with a normal
phenotype at birth and during adult life. Hoxb7-GFP-Tg mice (GFP expression
speciﬁcally in ureteric bud [UB] driven by Hoxb7 promoter), provided by
Dr. Frank Costantini (Columbia University Medical Center, New York, NY)
(30,31), were engineered to allow UB branching morphogenesis to be visualized
in real time in vivo as reported previously (28). CAT-Tg mice (e.g., rat CAT gene
overexpressing speciﬁcally in RPTCs driven by kidney-speciﬁc, androgen-
regulated protein [KAP] promoter) were obtained from Dr. John S.D. Chan
(CRCHUM) (32–34). High levels of androgens have been reported in the fetal
and maternal circulation in both humans (35–38) and mice (39), rendering the
KAP2 promoter a feasible way to direct CAT transgene expression during
nephrogenesis (which occurs in mice both in the prenatal and postnatal peri-
ods). We thus created hybrid Hoxb7/CAT-GFP-Tg mice by cross-breeding CAT-Tg
mice with Hoxb7-GFP-Tg mice; the resultant hybrid mice permit the visuali-
zation of CAT impact on nephrogenesis (e.g., UB branching morphogenesis),
which we examined both in the presence and absence of maternal diabetes
in vivo.
Induction of maternal diabetes. We have successfully used a single
intraperitoneal injection of 150 mg/kg body weight (BW) of streptozotocin
(Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) at embryonic day 13 (E13)
to create an in vivo murine model of maternal diabetes (26–29). We studied the
male offspring from nondiabetic (control) and diabetic dams of both Hoxb7-
GFP-Tg and Hoxb7/CAT-GFP-Tg.
Animal care. Animal care and the procedures used were approved by the
Institutional Animal Care Committee of the CRCHUM. Mice were housed under
standard humidity and lighting conditions (12-h light-dark cycles) with free
access to standard mouse chow and water.
Isolation of metanephroi and counting of UB tips. E15 embryos were
dissected aseptically from both timed-pregnant Hoxb7-GFP-Tg and Hoxb7/
CAT-GFP-Tgmice with or without diabetes. The E15metanephroi were isolated
under sterile conditions, and quantitative assessment of the number of UB tips
in each group was performed as reported previously (28).
Physiological studies. Blood glucose levels were measured with a Side-Kick
Glucose Analyzer (model 1500; InterScience, Markham, ON, Canada) in the
morning after a 4-h fast, as reported previously (26,27,29). Mean systolic BP
(SBP) was monitored by the tail-cuff method with the Visitech BP-2000 Blood
Pressure Analysis System for Mice (Visitech System Inc., Apex, NC), as re-
ported elsewhere (29,33,34). The animals were acclimated to BP measurement
(2-week period of pretraining starting at 6 weeks of age, followed by actual
measurement of SBP three times per week from 8 until 18 weeks of age).
Although the technique of tail-cuff measurement is generally considered less
sensitive than telemetry, we judged that our SBP data are valid, based on the
substantial numbers of animals used and the fact that the animals were well
acclimated and used to the measurement in our longitudinal studies, thus
minimizing stress.
Urine samples, collected from mice individually housed in metabolic
cages, were assayed for albumin and creatinine (ELISA; Albuwell and Cre-
atinine Companion; Exocell Inc., Philadelphia, PA) as reported previously
(29,33,34). All animals were killed at 20 weeks of age under CO2, and the
kidneys were removed immediately. BW and kidney weight (KW) were
rapidly recorded. The left kidney was used for renal morphology and im-
munohistochemistry (IHC) (29,33,34). The right kidney cortex was reserved
for ROS generation and gene expression experiments as previously reported
(29,33,34).
Measurement of glomerular ﬁltration rate. As reported previously (40), we
estimated the glomerular ﬁltration rate (GFR) in 20-week-old male animals
by the ﬂuorescein isothiocyanate–inulin (FITC-inulin) method, as described by
Qi et al. (41) and recommended by the Diabetes Complications Consortium
(www.diacomp.org).
Renal morphology, mean glomerular volume, and nephron number.
Kidney morphology was assessed with hematoxylin and eosin (H&E) and
periodic acid Schiff (PAS) staining. As in previous reports (26,27,29), mean
FIG. 1. Characterization of Hoxb7-GFP-Tg and Hoxb7/CAT-GFP-Tg mice. A: PCR genotyping. B: E15 metanephroi isolation either from Hoxb7-GFP-
Tg dam (nondiabetic, Hoxb7-Con [b1]; diabetic, Hoxb7-DM [b2]) or Hoxb7/CAT-GFP-Tg dam (nondiabetic, Hoxb7/CAT-Con [b3]; diabetic, Hoxb7/
CAT-DM [b4]). Original magniﬁcation 34. C: The number of E15 metanephroi UB tips. ●, Hoxb7-Con; ■, Hoxb7-DM; ◆, Hoxb7/CAT-Con; ▼,
Hoxb7/CAT-DM. **P £ 0.01 and ***P £ 0.001. NS, nonsigniﬁcant. (A high-quality color representation of this ﬁgure is available in the online issue.)
CATALASE EFFECT ON PERINATAL PROGRAMMING
2566 DIABETES, VOL. 61, OCTOBER 2012 diabetes.diabetesjournals.org
glomerular volume (Vg) was determined using PAS-stained images with the aid
of an image analysis software system (Motics Images Plus 2.0; Motic, Richmond,
BC, Canada) (42); quantiﬁcation of neonatal nephron number was adapted from
the Bertram method, using serial sections (43).
ROS generation. Freshly isolated renal cortex was used immediately for ROS
measurement by the lucigenin method, as described elsewhere (26,27,32,33).
ROS production was normalized by protein concentration and expressed as
relative light units per microgram protein.
Real-time quantitative PCR. Total RNA extracted from freshly isolated renal
cortex was assayed for gene expression by real-time quantitative PCR (RT-
qPCR), as reported previously (27,29,40). The Fast SYBR Green Mastermix Kit
and the 7500 Fast Real-Time PCR System (Applied Biosystems; Life Tech-
nologies, Foster City, CA) were used for this purpose (26,27,32,33).
Immunohistochemistry. IHC was performed by the standard avidin-biotin-
peroxidase complex method (ABC Staining System; Santa Cruz Biotechnologies,
Santa Cruz, CA), as described elsewhere (26,27,29). Polyclonal anti-CAT
FIG. 2. A: Neonatal renal morphology reviewed by H&E staining and CAT expression (CAT-IHC). Neonatal offspring (nondiabetic: Hoxb7-Con
[black frame] and Hoxb7/CAT-Con [blue frame] vs. diabetic: Hoxb7-DM [red frame] and Hoxb7/CAT-DM [purple frame]). Original magniﬁcation 34
and360. B: Quantiﬁcation of neonatal nephron number.□, nondiabetic offspring (Hoxb7-Con, n = 9; Hoxb7/CAT-Con, n = 8);■, diabetic offspring
(Hoxb7-DM, n = 7; Hoxb7/CAT-DM, n = 9). The y-axis shows the percentage of nephron number compared with the Hoxb7-GFP-Tg control animal
(Hoxb7-Con, 100%). **P £ 0.01 and ***P £ 0.001. NS, nonsigniﬁcant. (A high-quality digital representation of this ﬁgure is available in the online
issue.)
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antibody was purchased from Sigma-Aldrich Canada; polyclonal anti-Nrf2
antibody was purchased from Abcam (Cambridge, MA); and transforming
growth factor-b1 (TGF-b1) and HO-1 antibodies were purchased from Santa
Cruz Biotechnology.
Immortalized RPTCs. The immortalized RPTC (IRPTC) line reported pre-
viously (44) was used for our studies in vitro. This in vitro setting is useful for
studies of the effect of high glucose (25 mmol/L D-glucose) on both Nrf2 and
HO-1 gene expression, as well as Nrf2 nuclear translocation with or without
the administration of CAT (250 units). The cells incubated in low-glucose
(5 mmol/L D-glucose) medium with 20 mmol/L mannitol, to compensate for
the same osmolality as high glucose, serve as the control.
Nuclear protein and cytosolic protein extracts were prepared using the
NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientiﬁc,
Burlington, ON, Canada), as reported previously (26,27). Anti–histone H3
(3H1) rabbit mAb was purchased from Cell Signaling Technology, Inc.
(Boston, MA). Western blot (WB) and immunoﬂuorescence (IF) stain-
ing on both Nrf2 and HO-1 in IRPTCs were performed as reported pre-
viously (45).
Statistical analysis. Statistical signiﬁcance between the experimental groups
was analyzed by one-way ANOVA, followed by the Bonferroni test using
Graphpad Software, Prism 5.0 (http://www.graphpad.com/prism/prism.htm). A
probability level of P # 0.05 was considered to be statistically signiﬁcant
(26,27,29).
RESULTS
Hybrid Hoxb7/CAT-Tg mouse generation. The success
of generating hybrid Hoxb7/CAT-Tg mice was conﬁrmed
by PCR genotyping (Fig. 1A), as well as GFP live image in
E15 metanephroi (Fig. 1B). Once these animals were ob-
tained, we compared UB branching morphogenesis in E15
metanephroi after 2 days of streptozotocin administration
(e.g., maternal blood glucose concentration: nondiabetic
dams [Hoxb7-GFP-Tg, 9.45 6 1.69 mmol/L; Hoxb7/CAT-
GFP-Tg, 9.68 6 1.01 mmol/L] vs. diabetic dams [Hoxb7-
GFP-Tg, 28.66 2.14 mmol/L; Hoxb7/CAT-GFP-Tg, 27.96 2.0
mmol/L]). As compared with the E15 metanephroi isolated
from nondiabetic Hoxb7-GFP-Tg animals, the E15 meta-
nephroi from diabetic Hoxb7-GFP-Tg mice displayed smaller
size (Fig. 1B) with a smaller number of UB tips (Fig. 1C),
and those UB branching impairments appear to be amelio-
rated by diabetic Hoxb7/CAT-GFP-Tg mice (Fig. 1B and C).
Neonatal kidney outcomes in offspring. Neonatal renal
morphology was reviewed by H&E staining and CAT IHC.
CAT IHC revealed that CAT is highly expressed in RPTCs
in the neonatal kidneys of Hoxb7/CAT-GFP-Tg compared
with Hoxb7-GFP-Tg mice (Fig. 2A). As compared with the
offspring of nondiabetic Hoxb7-GFP-Tg dams, the neo-
nates of diabetic Hoxb7-GFP-Tg dams had smaller kid-
neys with small glomeruli (Fig. 2A), as well as fewer
nephrons (Fig. 2B). This dysnephrogenesis appeared to
be attenuated in the neonatal offspring of Hoxb7/CAT-
GFP-Tg diabetic dams (Fig. 2A and B). Also, there is no
FIG. 3. Physical parameters in the male offspring at 20 weeks of age. A: BW (g). B: KW (mg). C: Ratio of KW vs. BW. D: Fasting blood glucose
concentration (mmol/L). The y-axis shows the percentage of value compared with Hoxb7-Con (100%). □, nondiabetic offspring (Hoxb7-Con;
Hoxb7/CAT-Con); ■, diabetic offspring (Hoxb7-DM; Hoxb7/CAT-DM). *P £ 0.05 and **P £ 0.01. NS, nonsigniﬁcant.
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signiﬁcant difference in litter size and sex distribution among
the four groups of animals (Supplementary Fig. 1).
Physical and biochemical measurements in the male
offspring in adulthood. Figure 3 displays the physical
and biochemical ﬁndings in the male offspring at 20 weeks
of age. The offspring of Hoxb7-GFP-Tg diabetic dams
were signiﬁcantly smaller and lighter as compared with
the offspring of nondiabetic Hoxb7-GFP-Tg dams (BW
in Hoxb7-GFP-Tg offspring: nondiabetic [Hoxb7-control
(Con), 27.98 6 1.095 g, n = 16] vs. diabetic [Hoxb7–diabetes
(DM), 22.84 6 1.506 g, n = 12]; P # 0.05). In contrast, there
were no signiﬁcant differences between the BWs of the off-
spring from nondiabetic and diabetic Hoxb7/CAT-GFP-Tg
dams (Hoxb7/CAT-GFP-Tg offspring: nondiabetic [Hoxb7/CAT-
Con: 31.845 6 1.35 g, n = 13] vs. diabetic [Hoxb7/CAT-DM:
33.92 6 1.82 g, n = 14]) (Fig. 3A). Although the 20-week-old
male Hoxb7/CAT-GFP-Tg offspring had signiﬁcantly bigger
kidneys, as compared with those of Hoxb7-GFP-Tg mice
(Fig. 3B) (KW: Hoxb7-Con, 314.6 6 37.96 mg [n = 15];
Hoxb7-DM, 2986 41.31 mg [n = 10]; Hoxb7/CAT-Con, 3946
26.08 mg [n = 11]; Hoxb7/CAT-DM, 380 6 5.07 mg [n = 12]),
the KW to BW ratio among all groups of 20-week-old
animals, however, did not differ signiﬁcantly (Fig. 3C), as
well as the fasting blood glucose levels (in mmol/L) (Fig. 3D).
Mean SBP in adulthood. SBP as monitored by tail cuff is
shown in Fig. 4A and B from 8 to 20 weeks of age. Longitu-
dinal studies (Fig. 4A) revealed that the male offspring of
diabetic Hoxb7-GFP-Tg dams have signiﬁcantly higher SBP
over the follow-up period, as compared with the control
offspring. CAT overexpression in RPTCs seems to prevent
maternal diabetes–induced perinatal programming of hy-
pertension. Figure 4B summarized the SBP in the male off-
spring at 20 weeks (Hoxb7-Con, 108.74 6 3.21 mmHg [n =
23]; Hoxb7-DM, 125.47 6 2.08 mmHg [n = 21]; Hoxb7/CAT-
Con, 113.356 1.40 mmHg [n = 22]; Hoxb7/CAT-DM, 116.656
1.52 mmHg [n = 23]).
ROS generation and renal function assay in adulthood.
The offspring of nondiabetic Hoxb7-GFP-Tg dams at 20
weeks of age have signiﬁcantly augmented ROS generation
in their freshly isolated renal cortex as compared with the
offspring of diabetic Hoxb7-GFP-Tg dams (Fig. 4C). The
offspring of diabetic dams exhibited signiﬁcantly increased
urinary albumin/creatinine ratio (ACR) (Fig. 4D) (Hoxb7-
Con, 0.026 6 0.024 [n = 12], vs. Hoxb7-DM, 0.38 6 0.34 [n =
15]; P # 0.001) and GFR (Fig. 4E) (Hoxb7-Con, 21.50 6 2.0
[n = 6], vs. Hoxb7-DM, 36.1 6 5.2 [n = 6]; P # 0.01).
In contrast, offspring with overexpression of CAT did not
have an increase in renal ROS (Fig. 4C), ACR (Fig. 4D), and
GFR (Fig. 4E), irrespective of whether the dams were
nondiabetic or diabetic Hoxb7/CAT-GFP-Tg (ACR: Hoxb7/
CAT-Con, 0.0316 0.004 [n = 9], vs. Hoxb7/CAT-DM, 0.0876
0.11 [n = 8]; GFR: Hoxb7/CAT-Con, 22.22 6 2.39 [n = 7], vs.
Hoxb7/CAT-DM, 22.35 6 3.23 [n = 6]).
Renal morphology and TGF-b1 gene expression in
adulthood. Enhanced extracellular matrix (ECM) protein
expression and accumulation in glomeruli is a marker of
FIG. 4. Mean SBP, ROS generation, and renal function measurement in male offspring at 20 weeks of age. A: Longitudinal changes in mean SBP in
the male offspring from 8 to 20 weeks of age. B: Mean SBP in the male offspring at 20 weeks of age. C: ROS generation. ROS production was
normalized with protein concentration and expressed as relative light units (RLU) per microgram protein. D: Ratio of urinary albumin (mg/mL)/
creatinine (mg/100 mL) (ACR) measurement. E: GFR measurement.□, nondiabetic offspring (Hoxb7-Con; Hoxb7/CAT-Con);■, diabetic offspring
(Hoxb7-DM; Hoxb7/CAT-DM). *P £ 0.05, **P £ 0.01, and ***P £ 0.001. NS, nonsigniﬁcant.
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glomerular injury. PAS staining of kidney sections re-
vealed that ECM accumulation in the glomeruli (Figs. 5A)
and higher mean Vg (Fig. 5B) were more pronounced in
hypertensive offspring of diabetic Hoxb7-GFP-Tg dams; this
ﬁnding was attenuated in offspring of both diabetic and
nondiabetic Hoxb7/CAT-GFP-Tg dams (Fig. 5A and B).
TGF-b1 is a ROS-inducible gene that is overexpressed in
diabetes; it is directly associated with increases in ECM
accumulation and tubulointerstitial ﬁbrosis (10,11,44). In-
crements of TGF-b1 gene expression (Fig. 5C), pre-
dominantly localized to glomeruli and the tubulointerstitium,
were observed in kidneys of hypertensive Hoxb7-GFP-Tg
offspring (Fig. 5D). Further, the heightened TGF-b1 ex-
pression was attenuated in kidneys of offspring of diabetic
Hoxb7/CAT-GFP-Tg dams (Fig. 5C and D), indicating that
suppressing ROS generation ameliorated glomerular and
tubulointerstitial ﬁbrosis.
Nrf2–HO-1 gene expression in adulthood. We assessed
Nrf2 and HO-1 gene expression in the renal cortex using
RT-qPCR (Fig. 6A and B). Compared with offspring of
nondiabetic Hoxb7-GFP-Tg dams, both Nrf2 and HO-1
levels were signiﬁcantly increased in hypertensive offspring
of diabetic Hoxb7-GFP-Tg dams. Overexpression of CAT in
RPTCs further enhanced Nrf2 and HO-1 gene expression in
the affected male offspring of both nondiabetic and diabetic
Hoxb7/CAT-GFP-Tg dams.
Consistent with the RT-qPCR data (Fig. 6A and B), our
IHC studies (Fig. 6C) in parafﬁn-embedded renal sections
showed that Nrf2 protein expression was detected not
only in glomeruli, as reported by others (21,22), but also in
RPTCs, whereas HO-1 appeared limited to the RPTCs. Most
interestingly, the elevation of Nrf2 protein expression was
strikingly increased in RPTCs, accompanied by nuclear
translocation in offspring of Hoxb7/CAT-GFP-Tg dams, both
diabetic and nondiabetic, indicating that overexpression of
CAT in RPTCs activates the Nrf2–HO-1 defense system to
ameliorate maternal diabetes–induced perinatal programming
of kidney injury in offspring.
Nrf2–HO-1 gene expression in IRPTCs in vitro. To
conﬁrm the effect of CAT on Nrf2 translocation, we per-
formed additional in vitro studies with cultured IRPTCs
(44). In this in vitro system, as in vivo, high glucose (Fig.
7A–D) signiﬁcantly upregulates Nrf2 gene expression, as
well as its translocation from the cytosol to the nucleus,
which targets the downstream HO-1 gene, resulting in sig-
niﬁcant upregulation, implicating the Nrf2 antioxidative ma-
chinery in the operation. Meanwhile, CAT itself could trigger
Nrf2 translocation and further upregulate HO-1 expression in
FIG. 5. Renal morphology and TGF-b1 gene expression in the male offspring at 20 weeks of age. A: PAS staining (original magniﬁcation 360).
Hoxb7-Con (a1); Hoxb7-DM (a2); Hoxb7/CAT-Con (a3); Hoxb7/CAT-DM (a4). B: Quantiﬁcation of Vg value (Hoxb7-Con, n = 13; Hoxb7-DM, n = 9;
Hoxb7/CAT-Con, n = 7; and Hoxb7/CAT-DM, n = 6). The y-axis shows the percentage of Vg compared with Hoxb7-Con (100%). C: RT-qPCR of renal
TGF-b1 mRNA. The relative mRNA levels of TGF-b1 in the renal cortex were compared with their own b-actin mRNA. Hoxb7-Con values were
considered as 100%. Each point represents the mean 6 SD of three independent experiments. D: TGF-b1 IHC expression (original magniﬁcation
320 and 360). □, nondiabetic offspring (Hoxb7-Con; Hoxb7/CAT-Con);■, diabetic offspring (Hoxb7-DM; Hoxb7/CAT-DM). *P £ 0.05, **P £ 0.01,
and ***P £ 0.001. NS, nonsigniﬁcant. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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IRPTCs, indicating that the Nrf2–HO-1 antioxidative action
could be mediated in a CAT-dependent manner.
DISCUSSION
The present work demonstrates that intrarenal ROS gen-
eration induced by maternal diabetes can exert a direct
effect on nephrogenesis in utero, and consequently trigger
the perinatal programming of hypertension and renal injury
in the offspring of diabetic dams when they reach adult-
hood. CAT overexpression in RPTCs appears to prevent this
phenomenon, mediated, at least in part, by the Nrf2–HO-1
defense system.
In women with gestational diabetes, there is evidence of
increased oxidative stress and impairment of antioxidant
defense mechanisms, as seen in maternal plasma and cord
blood as well as in placental tissue (46). It appears that ROS
can directly impair nephrogenesis and elicit growth re-
tardation and congenital kidney anomalies (5–7), and may
also lead to adverse perinatal programming (26,29). In the
current study, we created a unique murine model, hybrid
Hoxb7/CAT-GFP-Tg mice, allowing us to directly study the
functional role of CAT in the impact of maternal diabetes
on nephrogenesis during the prenatal period and on the
development of perinatal programming of hypertension and
kidney injury in adulthood in the exposed male offspring.
First, we characterized our hybrid Hoxb7/CAT-GFP-Tg
mice and documented that the offspring of those Hoxb7/
CAT-GFP-Tg mice rendered diabetic during pregnancy
overexpress CAT in their RPTCs in isolated embryonic or
newborn kidneys, which could prevent maternal diabetes–
induced renal dysmorphogenesis (small kidneys with
decreased nascent nephron number as well as less UB
branching morphogenesis). One possible explanation is that
since common progenitors in the S-shaped body migrate
spontaneously and differentiate to form tubules (both
proximal and distal) and glomeruli (glomerular tufts),
tubulogenesis and glomerulogenesis directly inﬂuence each
other (47). Thus, if CAT overexpression in RPTCs elimi-
nates the impairment of maternal diabetes–induced ROS in
tubulogenesis, glomerulogenesis is improved as well. Nev-
ertheless, our data suggest that maternal diabetes–induced
renal ROS may exert a direct effect on nephrogenesis in
utero, and that the impaired nephrogenesis induced by ma-
ternal diabetes could be ameliorated by CAT overexpression
in RPTCs.
We previously reported that CAT overexpression in
RPTCs of db/db mice, which spontaneously develop
FIG. 6. Nrf2 and HO-1 gene expression in the male offspring at 20 weeks of age. RT-qPCR of Nrf2 (A) and HO-1 mRNA (B). The relative mRNA
levels of Nrf2 and HO-1 in the renal cortex were compared with their own b-actin mRNA. Hoxb7-Con values were considered as 100%. Each point
represents the mean 6 SD of three independent experiments. C: Nrf2 and HO-1 IHC expression (original magniﬁcation 320). □, nondiabetic
offspring (Hoxb7-Con; Hoxb7/CAT-Con);■, diabetic offspring (Hoxb7-DM; Hoxb7/CAT-DM). *P £ 0.05 and **P £ 0.01. NS, nonsigniﬁcant. (A high-
quality digital representation of this ﬁgure is available in the online issue.)
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diabetes, effectively attenuates hypertension, albuminuria,
interstitial ﬁbrosis, tubular apoptosis, and proapoptotic gene
expression (32,33), suggesting that CAT overexpression in
the RPTCs might provide a novel approach to obviating or
reversing the pathophysiological manifestations of maternal
diabetes–induced perinatal programming of hypertension
and kidney injury. Hence, we hypothesized that the pro-
tective role of CAT in RPTCs programmed for hypertension
and kidney injury by maternal diabetes might be mediated
through the Nrf2–HO-1 defense system.
To test this hypothesis, we followed male offspring of
nondiabetic and diabetic dams until adulthood (20 weeks
of age). We observed that the adult male offspring of diabetic
Hoxb7-GFP-Tg dams displayed higher renal ROS generation
and developed hypertension and renal injury features such
as microalbuminuria and renal hyperﬁltration (increased
GFR and mean Vg) and apparent glomerular injury (ECM
accumulation and tubulointerstitial ﬁbrosis) with heightened
TGF-b1 expression, as compared with male offspring
of diabetic Hoxb7-CAT-GFP-Tg dams. Thus, CAT overex-
pression in RPTCs of the male offspring of diabetic
Hoxb7/CAT-GFP-Tg dams appears to normalize these ab-
normalities with the upregulation of Nrf2 and HO-1 gene
expression in the kidney.
It has recently been reported that the Nrf2–HO-1 defense
system is renoprotective (20–24); further, a causal link be-
tween Nrf2 antioxidative pathways and oxidative stressors
(e.g., ROS, angiotensin II, TGF-b1, and NF-kB, etc.) has been
established (20–24,48). Thus, it seems likely that Nrf2-
mediated antioxidative capacity could act to counterbalance
the stress induced by increased ROS production. When Nrf2
signals are impaired, either by reduction of Nrf2 pathway
activation (20–24,48) or by disruption of Nrf2 gene expres-
sion (Nrf2 knockout mice) (21,49,50), renal damage may
worsen, suggesting Nrf2-dependent regulation. Our present
data indicate that overexpression of CAT in RPTCs pro-
motes Nrf2 gene expression, and then decreases TGF-b1–
related glomerular ECM accumulation, which conﬁrms the
ﬁndings of Jiang et al. (21), who reported that knockdown
of Nrf2 by small interfering RNA enhanced TGF-b1 tran-
scription and ﬁbronectin production in cultured human
mesangial cells. Moreover, previously, we established that
FIG. 7. High glucose (Glu) effects on Nrf2 and/or HO-1 protein expression as well as Nrf2 nuclear translocation analyzed by WB (A and B) and IF
staining (C and D) in IRPTCs in vitro. A: WB performed on the total cell lysis. B: WB performed on isolated nuclear protein (N.P.) and cytosolic
protein (C.P.) extracts. C: IF images (original magniﬁcation 320 and 360). D: Semiquantiﬁcation of Nrf2 IF nuclear-positive cells. The relative
blot densities of Nrf2 and HO-1 protein expression in IRPTCs were compared with their own b-actin or histone H3. The values in 5 mmol/L glucose
medium were considered as 100%. Each point represents the mean6 SD of three independent experiments. *P £ 0.05, **P £ 0.01, and ***P £ 0.001.
NS, nonsigniﬁcant. (A high-quality color representation of this ﬁgure is available in the online issue.)
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there is a functional relationship between intrarenal ROS
generation, the activation of the intrarenal renin-angiotensin
system, and the NF-kB signaling pathway in our maternal
diabetes murine model of perinatal programming (26,27,29).
Taken together, our data suggest that CAT is capable of
triggering Nrf2 translocation and then targeting downstream
genes, such as the HO-1 gene, which then interacts with the
intrarenal renin-angiotensin system and NF-kB signaling,
improving renal outcome (27,29,34).
Finally, we observed that the augmented upregulation of
Nrf2 with nuclear translocation was most evident in the
RPTCs, rather than in glomeruli, as reported by others
(21,22), whereas heightened HO-1 IHC expression seems to
only be localized in the RPTCs, in agreement with other
reports (20,22). Given this speciﬁc localization of Nrf2 ex-
pression in RPTCs, we further validated our in vivo data by
using IRPTCs in vitro (44). In addition to showing that CAT
eliminates ROS generation produced by either high glucose
milieu, we conﬁrmed that CAT itself could trigger Nrf2
translocation and further upregulate HO-1 expression in
IRPTCs, indicating that the antioxidative action of Nrf2–
HO-1 occurs in a CAT-dependent manner.
In conclusion, we demonstrated that CAT overexpression
in RPTCs could exert a direct effect on nephrogenesis in
utero and ameliorate maternal diabetes–induced dys-
nephrogenesis, consequently preventing maternal diabetes–
induced perinatal programming, mediated at least in part, by
the Nrf2–HO-1 defense system.
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